GGrantIndex
← Search

Phase 1-2 study of Lu177-DOTATATE and olaparib in neuroendocrine tumors

$85,115ZIAFY2024CANIH

Division Of Basic Sciences - Nci

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →